Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: michael i olson who wrote (3935)	12/3/1999 7:29:00 PM
From: Hogger	Read Replies (1) \| Respond to of 4028

Hey DD, Howzitall?? You make an interesting point about the trends in stock price and keeping it rolling uphill all month. I would love to see that, but it would scare me to find out that the company was THAT concerned about stock price. If they just keep dedicating their efforts to getting the product improved and more commercialized, IMHO, the stock price will take care of itself. I can't help but wonder if the swing this month is based to a large degree on the fact that the PCCA Joint Venture will be swinging along with seminars and training for the 2500+ pharmacists that will be doing the compounding. As that becomes a more widely utilized practice, the stock price will take care of itself. Hogger - Adm(Hon)

To: michael i olson who wrote (3935)	12/6/1999 8:56:00 AM
From: michael i olson	Read Replies (1) \| Respond to of 4028

Here is the first of the month annoucment. Monday December 6, 8:00 am Eastern Time Company Press Release CYGS Moves and Expands to Include Research Laboratories HOUSTON--(BUSINESS WIRE)--Dec. 6, 1999--Cryogenic Solutions Inc. (OTCBB:CYGS - news) has moved into newly completed space to accommodate the expanded staff and activities of the company. The office and laboratory facilities are adjacent to the headquarters building complex of Professional Compounding Centers of America Inc (PCCA). As previously announced, PCCA and CYGS have joined to form PharmaGenix LLC, a novel business entity conceived to combine the medical technologies of modern compounding pharmacy and genetically based skills and biotechnology. PharmaGenix(TM) will be operated out of the CYGS offices. The PharmaGenix structure is designed to provide the quickest and most efficient means of getting the promising new antisense therapies into the healthcare system working within existing state and federal regulations. The laboratory facilities will be used for basic research, product development, and training of compounding pharmacists in the cellular biology and biochemical techniques needed to formulate pharmacogenomic products. The new address for CYGS is 9881 S. Wilcrest, Houston, Texas 77099, telephone 281/988-6118, fax 281/988-6727. Additional information is available on the website at cygs.net.